Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00690703 · ClinicalTrials.gov registry record · Phase 2
Radiofrequency Ablation of Pulmonary Tumors Response Evaluation
A Phase 2 study, sponsored by Angiodynamics.
- Completed
- Registry status
- Phase 2
- Development phase
- 106
- Enrollment target
NCT00690703 is a Phase 2 study that has completed, run by Angiodynamics. The registered enrollment target is 106 participants.
The verdict
NCT00690703, a Phase 2 study, has completed, sponsored by Angiodynamics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 106 participants
- Enrollment target
Study Summary
The study hypothesis is that the radiofrequency (RF) ablation is a safe and effective treatment for malignant lung tumors.
Interventions
- DEVICE RF ablation (Rita Medical Systems Model 1500x)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2001-07 |
| Est. Completion | 2007-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00690703
The ClinicalTrials.gov registry entry for NCT00690703 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 106 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Angiodynamics, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which RF ablation (Rita Medical Systems Model 1500x) is the first listed.
NCT00690703 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00690703 about?
NCT00690703 is a clinical study titled "Radiofrequency Ablation of Pulmonary Tumors Response Evaluation". The study hypothesis is that the radiofrequency (RF) ablation is a safe and effective treatment for malignant lung tumors.
What is the current status of trial NCT00690703?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 106 participants. The study started on 2001-07. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00690703?
The interventions under investigation include: RF ablation (Rita Medical Systems Model 1500x) (DEVICE).
Who is sponsoring clinical trial NCT00690703?
This trial is sponsored by Angiodynamics, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.